Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globestar Therapeutics Corp (OP:GSTC)

0.0001 UNCHANGED
Last Price Updated: 2:25 PM EST, Dec 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globestar Therapeutics Corp

News headline image
Globestar Therapeutics Update on Project Amethyst(TM) and Recent Financials
Via ACCESSWIRE
News headline image
GlobeStar Therapeutics Enters Into Definitive Agreement With Advanced Innovative Partners To Develop Clinical Studies and Strategies for Multiple Sclerosis Treatment
Via ACCESSWIRE
News headline image
Globestar Therapeutics Enters into Definitive Agreement with SMI Healthcare to Manage Clinical Trial, Regulatory Filings, Manufacturing and Sales in MEA Region for Multiple Sclerosis Treatment
Via ACCESSWIRE
Transformative Therapies for Neurodegenerative Diseases; MOU with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis: GlobeStar Therapeutics (Stock Symbol: GSTC)
Via Get News
Topics Intellectual Property
News headline image
Globestar Therapeutics Enters into MOU with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis Treatment
Via ACCESSWIRE
News headline image
GlobeStar Therapeutics Corporation Update on Recent Activity
Via ACCESSWIRE
News headline image
CORRECTING and REPLACING GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract
Agency selected because of performance history and a deep understanding of the company's healthcare, technology, and lifestyle spaces. RICHLAND, WA / ACCESSWIRE / March 1, 2022 / GlobeStar Therapeutics... 
From GlobeStar Therapeutics Corporation
Via AccessWire
Topics Regulatory Compliance
News headline image
GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking Contract
Agency selected because of performance history and a deep understanding of the company's healthcare, technology, and lifestyle spaces. RICHLAND, WA / ACCESSWIRE / March 1, 2022 / GlobeStar Therapeutics... 
From GlobeStar Therapeutics Corporation
Via AccessWire
Topics Regulatory Compliance
News headline image
GlobeStar Therapeutics Corporation Addresses the Potential Link Between Neurodegenerative Disease and Parkinson’s Disease
Company will work with its team of professionals to determine if our proprietary medical treatment will help Parkinson's patients as well. RICHLAND, WA / ACCESSWIRE / February 4, 2022 / GlobeStar... 
From GlobeStar Therapeutics Corporation
Via AccessWire
News headline image
GlobeStar Therapeutics Corporation Has Been Upgraded to the QB Tier on OTC Markets
Company will move from the Pink tier to QB tier effective immediately while retaining the same ticker symbol. RICHLAND, WA / ACCESSWIRE / October 11, 2021 / GlobeStar Therapeutics Corporation... 
From AngioSoma, Inc.
Via AccessWire
News headline image
GlobeStar Therapeutics Corporation Additional Progress Toward A U.S.-Based Clinical Trial.
Company has made progress with a major medical center in the Northeast and identified a path forward for this pharmaceutical. RICHLAND, WA / ACCESSWIRE / October 4, 2021 / GlobeStar Therapeutics... 
From GlobeStar Therapeutics Corporation
Via AccessWire
News headline image
GlobeStar Therapeutics Corporation Files New 8K Statement Focused On Progress, Market Acceptance, And A Potential Game-Changing Drug For Multiple Sclerosis
Company has made significant progress and identified a path forward for this pharmaceutical. RICHLAND, WA / ACCESSWIRE / September 20, 2021 / GlobeStar Therapeutics Corporation (OTCBB: GSTC) has filed... 
From AngioSoma, Inc.
Via AccessWire
News headline image
GlobeStar Therapeutics Corporation Unveils New Corporate Website and Branding Campaign
New website goes live in tandem with a major branding campaign to be found in USA Today. RICHLAND, WA / ACCESSWIRE / July 21, 2021 / GlobeStar Therapeutics Corporation (OTC PINK:GSTC) is launching its... 
From AngioSoma, Inc.
Via AccessWire
News headline image
GlobeStar Therapeutics Corporation To Be Seen In The Washington Football Team Yearbook All Season
RICHLAND, WA / ACCESSWIRE / July 15, 2021 / GlobeStar Therapeutics Corporation has partnered with the Washington Football Team Yearbook producers for inclusion in their annual book. GlobeStar... 
From AngioSoma, Inc.
Via AccessWire
News headline image
AngioSoma, Inc. Is Officially GlobeStar Therapeutics Corporation.
FINRA Approval for the AngioSoma name change is effective immediately. RICHLAND, WA / ACCESSWIRE / July 6, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) is now officially GlobeStar Therapeutics Corporation... 
From AngioSoma, Inc.
Via AccessWire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.